IP Library › Assignment 046814/0374
Patent Assignment
Reel/Frame 046814/0374

Security Interest

Recorded: 2018-09-07 Pages: 6
Assignor
BIOVEN 3 LTD.
Executed: 2018-08-24
Assignees
INNOCORP VENTURES SDN. BHD.
3501 LEVEL 3, QUILL BUILDING 3, JALAN TEKNOKRAT 5, CYBERJAYA, SELANGOR DARUL EHSAN, 63000, MALAYSIA
HALFMOON BAY CAPITAL LTD
SUITE 10.3 10TH FLOOR WEST WING ROHAS PURECIRCLE, 9 JALAN P RAMLEE, KUALA LUMPUR, 50250, MALAYSIA
Covered Properties (3)
Recombinant Proteins and Their Therapeutic Uses
Patent: 9,902,760 →
Application: 13/813,844 →
Publication: US 2014/0248302
Epidermal Growth Factor Fusion Proteins with Mutant Cholera Toxin B Subunits
Application: 14/854,224 →
Publication: US 2016/0095910
Methods and Compositions for Inhibition of Egf/Egfr Pathway in Combination with Tyrosine Kinase Inhibitors
Application: 15/073,021 →
Publication: US 2016/0333087
Related Assignments (5)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Feb 4, 2016
From: CHARLTON, KEITH ALAN; D'HONDT, ERIK
To: BIOVEN 3 LIMITED
Reel/Frame 037661/0581 →
Assignment of Assignor's Interest Feb 4, 2016
From: VERHAMME, DANIEL T.
To: BIOVEN 3 LIMITED
Reel/Frame 037661/0687 →
Assignment of Assignor's Interest Jun 24, 2016
From: D'HONDT, ERIK; VILA, MIGUEL ÁNGEL MOLINA
To: BIOVEN 3 LIMITED
Reel/Frame 039001/0682 →
Change of Name Aug 2, 2019
From: BIOVEN 3 LTD.
To: IN3BIO LTD.
Reel/Frame 049940/0607 →
Security Interest Feb 4, 2026
From: IN3BIO LTD.
To: WITHERS BERGMAN LLP
Reel/Frame 074607/0289 →